Wolverine Asset Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-32,300
Closed -$177K 1636
2019
Q4
$177K Hold
32,300
﹤0.01% 993
2019
Q3
$184K Hold
32,300
﹤0.01% 1012
2019
Q2
$247K Hold
32,300
﹤0.01% 997
2019
Q1
$169K Sell
32,300
-14,700
-31% -$102K ﹤0.01% 1058
2018
Q4
$307K Buy
47,000
+42,300
+900% +$474K ﹤0.01% 1155
2018
Q3
$80K Buy
+4,700
New +$69.9K ﹤0.01% 1309

Other funds holding PGEN

Wolverine Asset Management's PGEN Position: Q1 2023 in Review

Wolverine Asset Management sold out of Precigen (PGEN) in Q1 2023, closing a stake of 140,887 shares — an estimated $214K sold.

Wolverine Asset Management first reported a position in PGEN in Q3 2022 and held it in 2 quarters. The position peaked at $214K in Q4 2022. 157 funds tracked by Wall St. Rank hold PGEN as of Q1 2023.

  • Wolverine Asset Management reported no remaining Precigen position as of Q1 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 140,887 Precigen shares in Q1 2023, an estimated $214K.
  • Wolverine Asset Management first reported a position in Precigen in Q3 2022 and held it in 2 quarters.
  • Wolverine Asset Management's Precigen position peaked at $214K in Q4 2022.
  • 157 funds tracked by Wall St. Rank held Precigen as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.